Moneycontrol
SENSEX NIFTY
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA | Series: NA | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Jul 15, 16:00
840.10 30.45 (3.76%)
Volume
AVERAGE VOLUME
5-Day
256,443
10-Day
181,402
30-Day
170,639
293,991
  • Prev. Close

    809.65

  • Open Price

    813.00

  • Bid Price (Qty.)

    838.00 (29)

  • Offer Price (Qty.)

    838.30 (4)

NSE Live

Jul 15, 15:56
840.05 30.70 (3.79%)
Volume
AVERAGE VOLUME
5-Day
4,233,806
10-Day
3,502,658
30-Day
4,618,307
4,661,394
  • Prev. Close

    809.35

  • Open Price

    811.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    840.05 (3152)

Financials

2019 2018 2017 2016 2015
Half Yearly Results of Aurobindo Pharma (in Rs. Cr.) Mar '20 Sep '19 Mar '19 Sep '18 Mar '18  
Net Sales/Income from operations 11,862.84 10,875.11 10,377.24 8,848.68 8,257.62  
Other Operating Income 190.59 169.96 184.63 152.99 127.58  
Total Income From Operations 12,053.43 11,045.07 10,561.87 9,001.67 8,385.20  
EXPENDITURE  
Consumption of Raw Materials 4,049.13 3,675.85 3,913.85 3,531.14 2,811.50  
Purchase of Traded Goods 1,066.34 1,045.77 1,064.06 879.15 909.56  
Increase/Decrease in Stocks -47.10 -54.76 -215.40 -460.15 -234.09  
Power & Fuel -- -- -- -- --  
Employees Cost 1,662.13 1,557.05 1,363.26 1,221.61 1,121.95  
Depreciation 482.54 484.17 349.74 318.21 294.71  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 2,798.67 2,529.76 2,292.25 2,132.59 1,962.59  
P/L Before Other Inc. , Int., Excpt. Items & Tax 2,041.72 1,807.23 1,794.11 1,379.12 1,518.98  
Other Income 63.52 31.62 96.12 69.99 76.88  
P/L Before Int., Excpt. Items & Tax 2,105.24 1,838.85 1,890.23 1,449.11 1,595.86  
Interest 68.94 90.83 97.73 64.93 43.58  
P/L Before Exceptional Items & Tax 2,036.30 1,748.02 1,792.50 1,384.18 1,552.28  
Exceptional Items -0.67 -25.46 -61.22 -26.84 --  
P/L Before Tax 2,035.63 1,722.56 1,731.28 1,357.34 1,552.28  
Tax 461.38 452.13 435.90 290.96 429.33  
P/L After Tax from Ordinary Activities 1,574.25 1,270.43 1,295.38 1,066.38 1,122.95  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 1,574.25 1,270.43 1,295.38 1,066.38 1,122.95  
Minority Interest 0.98 0.48 0.17 0.06 -0.10  
Share Of P/L Of Associates -19.95 4.78 2.05 0.65 0.67  
Net P/L After M.I & Associates 1,555.28 1,275.69 1,297.60 1,067.09 1,123.52  
Equity Share Capital 58.59 58.59 58.59 58.59 58.59  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 26.87 21.77 -- 18.21 --  
Diluted EPS -- 21.77 -- 18.21 --  
EPS After Extra Ordinary  
Basic EPS. 26.87 21.77 -- 18.21 --  
Diluted EPS. -- 21.77 -- 18.21 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited